BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35851967)

  • 1. Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy.
    Knight JC; Cornelissen B
    Am J Nucl Med Mol Imaging; 2014; 4(2):96-113. PubMed ID: 24753979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonyl Diazaborine 'Click' Chemistry Enables Rapid and Efficient Bioorthogonal Labeling.
    Chowdhury A; Chatterjee S; Kushwaha A; Nanda S; Dhilip Kumar TJ; Bandyopadhyay A
    Chemistry; 2023 Jul; 29(41):e202300393. PubMed ID: 37155600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Durable Attenuation of Tumor pH-Platelet Linkage Reinstates Bioorthogonal Targeting of Residual Tumors Post-Debulking.
    Zhang P; Li B; Wang Z; Li J; Wang F; Kong J; Zhou Z; Huang Y; Li L
    ACS Nano; 2024 Feb; 18(5):4520-4538. PubMed ID: 38270077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahippocampal Supramolecular Assemblies Directed Bioorthogonal Liberation of Neurotransmitters to Suppress Seizures in Freely Moving Mice.
    Wu C; Xie J; Yao Q; Song Y; Yang G; Zhao J; Zhang R; Wang T; Jiang X; Cai X; Gao Y
    Adv Mater; 2024 Apr; ():e2314310. PubMed ID: 38655719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer's sweet spot: techniques to harness saccharides in tumor biology.
    Parker J
    Biotechniques; 2024 Jan; 76(1):5-8. PubMed ID: 38047326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily briefing: Nobel for click and bioorthogonal chemistry.
    Graham F
    Nature; 2022 Oct; ():. PubMed ID: 36203056
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of a 99mTc-labeled tetrazine for pretargeted SPECT imaging using an alendronic acid-based bone targeting model.
    Bohrmann L; Poulie CBM; Rodríguez-Rodríguez C; Karagiozov S; Saatchi K; Herth MM; Häfeli UO
    PLoS One; 2024; 19(4):e0300466. PubMed ID: 38626058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A narrative review: progress in transition metal-mediated bioorthogonal catalysis for the treatment of solid tumors.
    Wan X; Zhang Y; Nie Y; Zhang K; Jin Z; Zhang Z; Gan L; Liu X; He J
    Transl Cancer Res; 2023 Aug; 12(8):2181-2196. PubMed ID: 37701121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Click Triazole as a Linker for Pretargeting Strategies: Synthesis, Docking Investigations, Fluorescence Diagnosis, and Antibacterial Action Studies.
    Liu Q; Zhao M; Song C; Sun J; Tao J; Sun B; Jiang J
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipophilicity and Click Reactivity Determine the Performance of Bioorthogonal Tetrazine Tools in Pretargeted
    Stéen EJL; Jørgensen JT; Denk C; Battisti UM; Nørregaard K; Edem PE; Bratteby K; Shalgunov V; Wilkovitsch M; Svatunek D; Poulie CBM; Hvass L; Simón M; Wanek T; Rossin R; Robillard M; Kristensen JL; Mikula H; Kjaer A; Herth MM
    ACS Pharmacol Transl Sci; 2021 Apr; 4(2):824-833. PubMed ID: 33860205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioorthogonal "Click and Release" Reaction-Triggered Aggregation of Gold Nanoparticles Combined with Released Lonidamine for Enhanced Cancer Photothermal Therapy.
    Yan X; Li K; Xie TQ; Jin XK; Zhang C; Li QR; Feng J; Liu CJ; Zhang XZ
    Angew Chem Int Ed Engl; 2024 Mar; 63(13):e202318539. PubMed ID: 38303647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in the Development of Tetrazine Ligation Tools for Pretargeted Nuclear Imaging.
    García-Vázquez R; Battisti UM; Herth MM
    Pharmaceuticals (Basel); 2022 May; 15(6):. PubMed ID: 35745604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody Pretargeting Based on Bioorthogonal Click Chemistry for Cancer Imaging and Targeted Radionuclide Therapy.
    Rondon A; Degoul F
    Bioconjug Chem; 2020 Feb; 31(2):159-173. PubMed ID: 31855602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioorthogonal Click of Colloidal Gold Nanoparticles to Antibodies In vivo.
    Poulie CBM; Sporer E; Hvass L; Jørgensen JT; Kempen PJ; Lopes van den Broek SI; Shalgunov V; Kjaer A; Jensen AI; Herth MM
    Chemistry; 2022 Nov; 28(61):e202201847. PubMed ID: 35851967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular Delivery of Bioorthogonal Pretargeting Therapeutics in PSMA-Positive Prostate Cancer.
    Hapuarachchige S; Huang CT; Donnelly MC; Bařinka C; Lupold SE; Pomper MG; Artemov D
    Mol Pharm; 2020 Jan; 17(1):98-108. PubMed ID: 31840521
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.